Surgical reconstructionFrom flat sheets to flowable 3D.
TT101 has been submitted to the FDA through the De Novo pathway for surgical wound repair.
MAP™ is a fully synthetic, flowable, porous biomaterial. It is designed to support cell infiltration, vascularization and new tissue formation, and is gradually replaced by the patient's own tissue.

Flowable microparticles can conform to irregular wound spaces.
After surgery or debridement, surgeons rely on sheet-based matrices and staged repair before a graft or closure. MAP™ is a flowable scaffold that fills the whole defect.
“The ability to regenerate tissue throughout the volume of a complex wound, rather than simply promoting healing from the margins, could fundamentally change the way difficult wounds are treated.”Westbrook Weaver, PhD · Co-Founder and CTO
Flowable microparticles link together in the wound into a stable scaffold with open pores, so cells can move in immediately. Explore the platform →

Open, connected pores give cells immediate access.

Particles link together and lock porosity into the tissue.

Flowable microparticles conform to irregular spaces.
Surgical reconstruction and wound healing first, with regenerative aesthetics in development. View programs →
Surgical reconstructionTT101 has been submitted to the FDA through the De Novo pathway for surgical wound repair.


Drag to compare
Tempo is exploring aesthetic applications through MAP™ formulation variants focused on tissue quality and regenerative outcomes.
A randomized study of MAP™ against standard hydrocolloid care in full-thickness wounds after Mohs surgery. See the full study →
Surgery and MAP™ applied
to a favorable wound bed score
improved physician-assessed scar quality
From formulation to regulatory review. Pipeline and milestones →
Led by cofounders Westbrook Weaver, PhD and Donald Griffin, PhD. Meet the team →
Research & industry collaborators